Literature DB >> 26185885

Effective balloon-occluded retrograde transvenous obliteration of the superior mesenteric vein-inferior vena cava shunt in a patient with hepatic encephalopathy after living donor liver transplantation.

Zhassulan Baimakhanov1, Akihiko Soyama, Mitsuhisa Takatsuki, Yusuke Inoue, Hajime Matsushima, Masaaki Hidaka, Amane Kitasato, Tomohiko Adachi, Tamotsu Kuroki, Ichiro Sakomoto, Susumu Eguchi.   

Abstract

Balloon-occluded retrograde transvenous obliteration (BRTO) has become a common and effective procedure for treating hepatic encephalopathy due to a portosystemic shunt related to cirrhosis of the liver. However, this method of treatment has rarely been reported in patients after liver transplantation. Here, we report the case of a 52-year-old patient who underwent living donor liver transplantation (LDLT) due to hepatitis C virus-infected hepatocellular carcinoma that was complicated with portal vein thrombosis and a large portosystemic shunt between the superior mesenteric vein (SMV) and inferior vena cava (IVC). The SMV-IVC shunt was not obliterated during LDLT because there was sufficient portal flow into the graft after reperfusion. However, the patient was postoperatively complicated with encephalopathy due to the portosystemic shunt. BRTO was performed and was demonstrated to have effectively managed the encephalopathy due to the SMV-IVC shunt, while preserving the hepatic function after LDLT.

Entities:  

Mesh:

Year:  2014        PMID: 26185885     DOI: 10.1007/s12328-014-0495-1

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  14 in total

1.  Direct measurement of hepatic blood flow in native and transplanted organs, with accompanying systemic hemodynamics.

Authors:  A W Paulsen; G B Klintmalm
Journal:  Hepatology       Date:  1992-07       Impact factor: 17.425

2.  Balloon-occluded retrograde transvenous obliteration (BRTO) for a direct shunt between the inferior mesenteric vein and the inferior vena cava in a patient with hepatic encephalopathy.

Authors:  Kenji Ibukuro; Toru Sugihara; Rei Tanaka; Hozumi Fukuda; Shoko Abe; Kimiko Tobe; Ryosuke Tateishi; Kazumi Tagawa
Journal:  J Vasc Interv Radiol       Date:  2007-01       Impact factor: 3.464

3.  Does the permanent portacaval shunt for a small-for-size graft in a living donor liver transplantation do more harm than good?

Authors:  T Oura; M Taniguchi; T Shimamura; T Suzuki; K Yamashita; M Uno; R Goto; M Watanabe; T Kamiyama; M Matsushita; H Furukawa; S Todo
Journal:  Am J Transplant       Date:  2007-12-18       Impact factor: 8.086

4.  Treatment of hepatic encephalopathy due to inferior mesenteric vein/inferior vena cava and gonadal vein shunt using dual balloon-occluded retrograde transvenous obliteration.

Authors:  Rei Tanaka; Kenji Ibukuro; Shoko Abe; Kimiko Tobe; Hozumi Fukuda; Yuji Kondou; Kazumi Tagawa
Journal:  Cardiovasc Intervent Radiol       Date:  2008-10-07       Impact factor: 2.740

5.  Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration.

Authors:  H Kanagawa; S Mima; H Kouyama; K Gotoh; T Uchida; K Okuda
Journal:  J Gastroenterol Hepatol       Date:  1996-01       Impact factor: 4.029

6.  Changes of portosystemic collaterals and splenic volume on CT after liver transplantation and factors influencing those changes.

Authors:  Se Hyung Kim; Jeong Min Lee; Jin Young Choi; Kyung-Suk Suh; Nam-Joon Yi; Joon Koo Han; Byung Ihn Choi
Journal:  AJR Am J Roentgenol       Date:  2008-07       Impact factor: 3.959

7.  The outcome of living donor liver transplantation with prior spontaneous large portasystemic shunts.

Authors:  Hiroshi Sadamori; Takahito Yagi; Hiroyoshi Matsukawa; Hiroaki Matsuda; Susumu Shinoura; Yuzo Umeda; Takayuki Iwamoto; Daisuke Satoh; Noriaki Tanaka
Journal:  Transpl Int       Date:  2007-11-12       Impact factor: 3.782

8.  Transvenous variceal embolization during or after living-donor liver transplantation to improve portal venous flow.

Authors:  Jin Hyoung Kim; Gi-Young Ko; Kyu-Bo Sung; Hyun-Ki Yoon; Kyung Rae Kim; Deok-Bog Moon; Sung-Gyu Lee
Journal:  J Vasc Interv Radiol       Date:  2009-11       Impact factor: 3.464

9.  Balloon-occluded retrograde transvenous obliteration in a patient with hyperammonemic encephalopathy after living donor liver transplantation.

Authors:  Satoshi Yokoyama; Mureo Kasahara; Akinari Fukuda; Shinji Uemoto; Shunsuke Nosaka
Journal:  Liver Transpl       Date:  2007-08       Impact factor: 5.799

10.  Balloon-occluded retrograde transvenous obliteration is feasible for prolonged portosystemic shunts after living donor liver transplantation.

Authors:  Yoshihiro Nagao; Tomohiko Akahoshi; Hideo Uehara; Naotaka Hashimoto; Nao Kinjo; Hirofumi Kawanaka; Morimasa Tomikawa; Hideaki Uchiyama; Tomoharu Yoshizumi; Yuuji Soejima; Ken Shirabe; Yoshihiko Maehara
Journal:  Surg Today       Date:  2013-03-07       Impact factor: 2.549

View more
  3 in total

1.  Endovascular management of portal steal syndrome due to portosystemic shunts after living donor liver transplantation.

Authors:  Surabhi Jajodia; Anubhav H Khandelwal; Rohit Khandelwal; Abhay K Kapoor; Sanjay S Baijal
Journal:  JGH Open       Date:  2021-04-04

2.  Prediction of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt treatment: a cohort study.

Authors:  Yang Yang; Sirui Fu; Bin Cao; Kenan Hao; Yong Li; Jianwen Huang; Wenfeng Shi; Chongyang Duan; Xiao Bai; Kai Tang; Shirui Yang; Xiaofeng He; Ligong Lu
Journal:  Hepatol Int       Date:  2021-05-11       Impact factor: 6.047

3.  Management of Spontaneous Portosystemic Shunts in 231 Patients Who Underwent Living Donor Liver Transplantation: A Retrospective Study from a Single Center in Nagasaki, Japan.

Authors:  Takashi Hamada; Masaaki Hidaka; Akihiko Soyama; Takanobu Hara; Hajime Imamura; Hajime Matsushima; Takayuki Tanaka; Tomohiko Adachi; Kengo Kanetaka; Susumu Eguchi
Journal:  Ann Transplant       Date:  2022-08-23       Impact factor: 1.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.